trientine has been researched along with deferoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, NE; Cotter, MA | 1 |
| Aaseth, J; Andersen, O; Cao, Y; Skaug, MA | 1 |
1 review(s) available for trientine and deferoxamine
| Article | Year |
|---|---|
Chelation in metal intoxication--Principles and paradigms.
Topics: Administration, Oral; Antidotes; Benzoates; Chelating Agents; Deferasirox; Deferiprone; Deferoxamine; Heavy Metal Poisoning; Humans; Penicillamine; Poisoning; Pyridones; Succimer; Triazoles; Trientine; Unithiol | 2015 |
1 other study(ies) available for trientine and deferoxamine
| Article | Year |
|---|---|
Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.
Topics: Animals; Cell Hypoxia; Chelating Agents; Chelation Therapy; Deferoxamine; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Free Radical Scavengers; Free Radicals; Glucose; Glycosylation; Ischemia; Male; Metals; Neural Conduction; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Regional Blood Flow; Sciatic Nerve; Streptozocin; Trientine | 1995 |